|
REVIEWS
|
| Hypomethylating Agents in Oncohematology
AD Shirin, OYu Baranova |
PDF
|
|
BONE MARROW TRANSPLANTATION
|
| Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemias with Hyperdiploid Karyotype
TL Gindina, NN Mamaev, ES Nikolaeva, SN Bondarenko, OA Slesarchuk, AS Borovkova, SV Razumova, OV Pirogova, AL Alyanskii, LS Zubarovskaya, BV Afanas’ev |
PDF
|
| Prevention of Acute Graft-Versus-Host Reaction after Allogeneic Unrelated Hematopoietic Stem Cell Transplantation: Comparison of Effectiveness of Treatment Regimens Based on Anti-Thymocyte Globulin and Cyclophosphamide
OV Pirogova, IS Moiseev, EV Babenko, OA Slesarchuk, OV Paina, SN Bondarenko, EV Morozova, AL Alyanskii, BV Afanas’ev |
PDF
|
| LYMPHOID TUMORS |
| Brentuximab Vedotin: New Possibilities for Treatment of Relapses and Refractory Hodgkin’s Lymphomas
EA Demina |
PDF
|
| Role of Positron-Emission Tomography in Prognosis of Outcomes of High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Hodgkin’s Lymphoma
VG Potapenko, NB Mikhailova, BI Smirnov, IA Skorokhod, DA Chaginskaya, VV Ryabchikova, IA Samorodova, EI Podol’tseva, VV Ipatov, IV Boikov, VN Semelev, DA Gornostaev, TG Potapenko, TG Kulibaba, NV Medvedeva, BV Afanas’ev |
PDF
|
| Factors Affecting Course and Outcome of Chronic Lymphocytic Leukemia: Data from Hematological Hospitals of Krasnoyarsk Region
VI Bakhtina, IV Demko, AN Narkevich, DS Gushchin |
PDF
|
| Non-Hodgkin’s Lymphomas in Children: 25-Year Clinical Experience
TT Valiev, AV Popa, AS Levashov, ES Belyaeva, NS Kulichkina, BV Kurdyukov, RS Ravshanova, GL Mentkevich |
PDF
|
| Elotuzumab for Treatment of Multiple Myeloma (Literature Review)
OM Votyakova |
PDF
|
| MYELOID TUMORS |
| Rearrangement of 11q23 Chromosome Region in Acute Myeloid Leukemias in Children
EV Fleishman, OI Sokova, AV Popa, GA Tsaur, LN Konstantinova, OM Plekhanova, MV Strigaleva, ES Nokhrina, VS Nemirovchenko, OR Arakaev |
PDF
|
| Molecular Monitoring of RUNX1-RUNX1T1 Transcript Level in Acute Myeloblastic Leukemias on Treatment
LL Girshova, EG Ovsyannikova, SO Kuzin, EN Goryunova, RI Vabishchevich, AV Petrov, DV Motorin, DV Babenetskaya, VV Ivanov, KV Bogdanov, IV Kholopova, TS Nikulina, YuV Mirolyubova, YuA Alekseeva, AYu Zaritskii |
PDF
|
|
COMPLICATIONS OF ANTITUMOR TREATMENT
|
| Biochemical Markers of Cardiotoxicity of High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with Malignant Lymphoproliferative Disorders
VO Sarzhevskii, DS Kolesnikova, VYa Mel’nichenko |
PDF
|
| Arterial Events in Patients with Chronic Myeloid Leukemia Receiving Treatment with Second Generation Tyrosine Kinase Inhibitors
GA Gusarova, AG Turkina |
PDF
|
|
CONGRESSES, CONFERENCES, SYMPOSIA
|
| Materials of the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation (April, 2016; Valencia) |
PDF
|
